The Genome Editing Revolution: Review Ahmad M
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Restriction Endonucleases
Molecular Biology Problem Solver: A Laboratory Guide. Edited by Alan S. Gerstein Copyright © 2001 by Wiley-Liss, Inc. ISBNs: 0-471-37972-7 (Paper); 0-471-22390-5 (Electronic) 9 Restriction Endonucleases Derek Robinson, Paul R. Walsh, and Joseph A. Bonventre Background Information . 226 Which Restriction Enzymes Are Commercially Available? . 226 Why Are Some Enzymes More Expensive Than Others? . 227 What Can You Do to Reduce the Cost of Working with Restriction Enzymes? . 228 If You Could Select among Several Restriction Enzymes for Your Application, What Criteria Should You Consider to Make the Most Appropriate Choice? . 229 What Are the General Properties of Restriction Endonucleases? . 232 What Insight Is Provided by a Restriction Enzyme’s Quality Control Data? . 233 How Stable Are Restriction Enzymes? . 236 How Stable Are Diluted Restriction Enzymes? . 236 Simple Digests . 236 How Should You Set up a Simple Restriction Digest? . 236 Is It Wise to Modify the Suggested Reaction Conditions? . 237 Complex Restriction Digestions . 239 How Can a Substrate Affect the Restriction Digest? . 239 Should You Alter the Reaction Volume and DNA Concentration? . 241 Double Digests: Simultaneous or Sequential? . 242 225 Genomic Digests . 244 When Preparing Genomic DNA for Southern Blotting, How Can You Determine If Complete Digestion Has Been Obtained? . 244 What Are Your Options If You Must Create Additional Rare or Unique Restriction Sites? . 247 Troubleshooting . 255 What Can Cause a Simple Restriction Digest to Fail? . 255 The Volume of Enzyme in the Vial Appears Very Low. Did Leakage Occur during Shipment? . 259 The Enzyme Shipment Sat on the Shipping Dock for Two Days. -
Redesign of Extensive Protein–DNA Interfaces of Meganucleases Using Iterative Cycles of in Vitro Compartmentalization
Redesign of extensive protein–DNA interfaces of meganucleases using iterative cycles of in vitro compartmentalization Ryo Takeuchi, Michael Choi, and Barry L. Stoddard1 Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 Edited by David Baker, University of Washington, Seattle, WA, and approved February 13, 2014 (received for review November 8, 2013) LAGLIDADG homing endonucleases (meganucleases) are sequence- residues. Although an industrial-scale engineering pipeline for specific DNA cleavage enzymes used for genome engineering. altering meganuclease specificity has been developed (6), the Recently, meganucleases fused to transcription activator-like effec- specialized knowledge and technology required for that ap- tors have been demonstrated to efficiently introduce targeted proach generally precludes their use by academic laboratories. genome modifications. However, retargeting meganucleases to In addition, a recent study has demonstrated that MegaTALs genomic sequences of interest remains challenging because it usu- (fusions of TAL effector DNA binding regions to meganucleases) ally requires extensive alteration of a large number of amino acid can induce a high level of targeted gene modification in human residues that are situated in and near the DNA interface. Here we cells (21). However, the utility of this platform still depends upon describe an effective strategy to extensively redesign such an the development of efficient strategies to engineer meganucleases extensive biomolecular interface. -
Re-Coding the ‘Corrupt’ Code: CRISPR-Cas9 Interventions in Human Germ Line Editing
Re-coding the ‘corrupt’ code: CRISPR-Cas9 interventions in human germ line editing CRISPR-Cas9, Germline Intervention, Human Cognition, Human Rights, International Regulation Master Thesis Tilburg University- Law and Technology 2018-19 Tilburg Institute for Law, Technology, and Society (TILT) October 2019 Student: Srishti Tripathy Supervisors: Prof. Dr. Robin Pierce SRN: 2012391 Dr. Emre Bayamlioglu ANR: 659785 Re-coding the ‘corrupt’ code CRISPR-Cas9, Germline Intervention, Human Cognition, Human Rights, International Regulation This page is intentionally left blank 2 Re-coding the ‘corrupt’ code CRISPR-Cas9, Germline Intervention, Human Cognition, Human Rights, International Regulation 3 Re-coding the ‘corrupt’ code CRISPR-Cas9, Germline Intervention, Human Cognition, Human Rights, International Regulation Table of Contents CHAPTER 1: Introduction .............................................................................................................. 6 1.1 Introduction and Review - “I think I’m crazy enough to do it” ......................................................................... 6 1.2 Research Question and Sub Questions .......................................................................................................................... 9 1.4 Methodology ............................................................................................................................................................................. 9 1.4 Thesis structure: ................................................................................................................................................................. -
Ep 2522723 B1
(19) TZZ ¥_T (11) EP 2 522 723 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: C12N 9/22 (2006.01) C12N 15/55 (2006.01) 03.12.2014 Bulletin 2014/49 C12N 15/10 (2006.01) A61K 48/00 (2006.01) A01K 67/027 (2006.01) A01H 1/00 (2006.01) (21) Application number: 12176308.0 (22) Date of filing: 28.01.2004 (54) Custom-made meganuclease and use thereof Maßgeschneiderte Meganuklease und Verwendung davon Méganucléase sur mesure et son utilisation (84) Designated Contracting States: • Paques, Frédéric AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 92340 Bourg-La-Reine (FR) HU IE IT LI LU MC NL PT RO SE SI SK TR •Perez-Michaut, Christophe 75016 Paris (FR) (30) Priority: 28.01.2003 US 442911 P • Smith, Julianne 01.08.2003 US 491535 P 92350 Le Plessis Robinson (FR) • Sourdive, David (43) Date of publication of application: 92300 Levallois Perret (FR) 14.11.2012 Bulletin 2012/46 (74) Representative: Leblois-Préhaud, Hélène Marthe (62) Document number(s) of the earlier application(s) in Georgette et al accordance with Art. 76 EPC: Cabinet Orès 04705873.0 / 1 590 453 36, rue de St Pétersbourg 75008 Paris (FR) (73) Proprietor: Cellectis 75013 Paris (FR) (56) References cited: • LUCAS PATRICK ET AL: "Rapid evolution of the (72) Inventors: DNA-binding site in LAGLIDADG homing • Arnould, Sylvain endonucleases", NUCLEIC ACIDS RESEARCH, 93200 Saint-Denis (FR) OXFORD UNIVERSITY PRESS, SURREY, GB, vol. • Bruneau, Sylvia 29, no. -
Improving Treatment of Genetic Diseases with Crispr-Cas9 Rna-Guided Genome Editing
Sanchez 3:00 Team R06 Disclaimer: This paper partially fulfills a writing requirement for first-year (freshmen) engineering students at the University of Pittsburgh Swanson School of Engineering. This paper is a student paper, not a professional paper. This paper is not intended for publication or public circulation. This paper is based on publicly available information, and while this paper might contain the names of actual companies, products, and people, it cannot and does not contain all relevant information/data or analyses related to companies, products, and people named. All conclusions drawn by the authors are the opinions of the authors, first- year (freshmen) students completing this paper to fulfill a university writing requirement. If this paper or the information therein is used for any purpose other than the authors' partial fulfillment of a writing requirement for first-year (freshmen) engineering students at the University of Pittsburgh Swanson School of Engineering, the users are doing so at their own--not at the students', at the Swanson School's, or at the University of Pittsburgh's--risk. IMPROVING TREATMENT OF GENETIC DISEASES WITH CRISPR-CAS9 RNA-GUIDED GENOME EDITING Arijit Dutta [email protected] , Benjamin Ahlmark [email protected], Nate Majer [email protected] Abstract—Genetic illnesses are among the most difficult to treat as it is challenging to safely and effectively alter DNA. INTRODUCTION: THE WHAT, WHY, AND DNA is the basic code for all hereditary traits, so any HOW OF CRISPR-CAS9 alteration to DNA risks fundamentally altering the way someone’s genes are expressed. This change could lead to What Is CRISPR-Cas9? unintended consequences for both the individual whose DNA was altered and any offspring they may have in the future, CRISPR-Cas9 is an acronym that stands for “Clustered compounding the risk. -
Numerical and Structural Chromosome Aberrations in Cauliflower (Brassica Oleracea Var
Numerical and structural chromosome aberrations in cauliflower (Brassica oleracea var. botrytis) and Arabidopsis thaliana Xianwen Ji Thesis committee Promotor Prof. Dr J.H.S.G.M. de Jong Personal chair at the Laboratory of Genetics Wageningen University Co-promotor Dr E. Wijnker Researcher at the University of Hamburg, Germany Other members Prof. Dr G.C. Angenent, Wageningen University Dr G.F. Sanchez Perez, Wageningen University Dr A.B. Bonnema, Wageningen University Dr K. van Dun, Rijk Zwaan Breeding Company, Fijnaart, the Netherlands This research was conducted under the auspices of the Graduate School of Experimental Plant Sciences Numerical and structural chromosome aberrations in cauliflower (Brassica oleracea var. botrytis) and Arabidopsis thaliana Xianwen Ji Thesis submitted in fulfillment of the requirements for the degree of doctor at Wageningen University by the authority of the Rector Magnificus Prof. Dr M.J. Kropff, in the presence of the Thesis Committee appointed by the Academic Board to be defended in public on Friday 5 December 2014 at 1.30 p.m. in the Aula Xianwen Ji Numerical and structural chromosome aberrations in cauliflower Brassica( oleracea var. botrytis) and Arabidopsis thaliana 137 pages PhD thesis, Wageningen University, Wageningen, NL (2014) With references, with summaries in English, Dutch and Chinese ISBN 978-94-6257-160-0 Contents Chapter 1 General Introduction 7 Chapter 2 FISH painting with repetitive DNA sequences for chromosome identification in aneuploid cauliflower (Brassica oleracea L. var. botrytis) 29 Chapter 3 Cross-species chromosome painting with Arabidopsis BACs on cauliflower (Brassica oleracea L. var. botrytis for karyotype analysis and chromosome identification 47 Chapter 4 Meiotic aberrations leading to aneuploidy in Cauliflower (Brassica oleracea L. -
New Plant Breeding Techniques 2013 Workshop Report
NEW PLANT BREEDING TECHNIQUES REPORT OF A WORKSHOP HOSTED BY FOOD STANDARDS AUSTRALIA NEW ZEALAND AUGUST 2013 DISCLAIMER FSANZ disclaims any liability for any loss or injury directly or indirectly sustained by any person as a result of any use of or reliance upon the content of this report. The content of this report is a summary of discussions of an external expert panel and does not necessarily reflect the views of FSANZ or FSANZ staff. The information in this report is provided for information purposes only. No representation is made or warranty given as to the suitability of any of the content for any particular purpose or to the professional qualifications of any person or company referred to therein. The information in this report should not be relied upon as legal advice or used as a substitute for legal advice. You should also exercise your own skill, care and judgement before relying on this information in any important matter and seek independent legal advice, including in relation to compliance with relevant food legislation and the Australia New Zealand Food Standards Code. 1 CONTENTS Disclaimer .......................................................................................................................... 1 EXECUTIVE SUMMARY ................................................................................................... 3 INTRODUCTION AND BACKGROUND ............................................................................. 5 DISCUSSION OF THE TECHNIQUES ............................................................................. -
Development of Genome Editing Approaches Against Herpes Simplex Virus Infections
viruses Review Development of Genome Editing Approaches against Herpes Simplex Virus Infections Isadora Zhang 1, Zoe Hsiao 1,2 and Fenyong Liu 1,3,* 1 School of Public Health, University of California, Berkeley, CA 94720, USA; [email protected] (I.Z.); [email protected] (Z.H.) 2 Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720, USA 3 Program in Comparative Biochemistry, University of California, Berkeley, CA 94720, USA * Correspondence: [email protected]; Tel.: +1-510-643-2436; Fax: +1-510-643-9955 Abstract: Herpes simplex virus 1 (HSV-1) is a herpesvirus that may cause cold sores or keratitis in healthy or immunocompetent individuals, but can lead to severe and potentially life-threatening complications in immune-immature individuals, such as neonates or immune-compromised patients. Like all other herpesviruses, HSV-1 can engage in lytic infection as well as establish latent infection. Current anti-HSV-1 therapies effectively block viral replication and infection. However, they have little effect on viral latency and cannot completely eliminate viral infection. These issues, along with the emergence of drug-resistant viral strains, pose a need to develop new compounds and novel strategies for the treatment of HSV-1 infection. Genome editing methods represent a promising approach against viral infection by modifying or destroying the genetic material of human viruses. These editing methods include homing endonucleases (HE) and the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR associated protein (Cas) RNA-guided nuclease system. Recent studies have showed that both HE and CRISPR/Cas systems are effective in inhibiting HSV- 1 infection in cultured cells in vitro and in mice in vivo. -
Strategies for Precision Modulation of Gene Expression by Epigenome Editing: an Overview Benjamin I
Laufer and Singh Epigenetics & Chromatin (2015) 8:34 DOI 10.1186/s13072-015-0023-7 REVIEW Open Access Strategies for precision modulation of gene expression by epigenome editing: an overview Benjamin I. Laufer* and Shiva M. Singh Abstract Genome editing technology has evolved rather quickly and become accessible to most researchers. It has resulted in far reaching implications and a number of novel designer systems including epigenome editing. Epigenome editing utilizes a combination of nuclease-null genome editing systems and effector domains to modulate gene expression. In particular, Zinc Finger, Transcription-Activator-Like Effector, and CRISPR/Cas9 have emerged as modular systems that can be modified to allow for precision manipulation of epigenetic marks without altering underlying DNA sequence. This review contains a comprehensive catalog of effector domains that can be used with components of genome editing systems to achieve epigenome editing. Ultimately, the evidence-based design of epigenome editing offers a novel improvement to the limited attenuation strategies. There is much potential for editing and/or correcting gene expression in somatic cells toward a new era of functional genomics and personalized medicine. Keywords: Regulation of gene expression, Functional genomics, Stem cells, dCas9, CRISPR/Cas9, Zinc Finger, Transcription-Activator-Like Effector (TALE), Synthetic biology Background editing systems rely on two components, a DNA-bind- The modulation of gene expression can be achieved by ing element, and nuclease, to modify the targeted DNA a variety of biotechnologies such as RNA interference, sequence. Genome editing can be used to study protein non-precision drugs, and artificial transcription factors function by altering coding sequence or achieve tran- (ATFs). -
DNA Damage Alters Nuclear Mechanics Through Chromatin Reorganisation
bioRxiv preprint doi: https://doi.org/10.1101/2020.07.10.197517; this version posted July 11, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. DNA damage alters nuclear mechanics through chromatin reorganisation Ália dos Santos1, Alexander W. Cook1, Rosemarie E Gough1, Martin Schilling2, Nora Aleida Olszok2, Ian Brown3, Lin Wang4, Jesse Aaron5, Marisa L. Martin-Fernandez4, Florian Rehfeldt2,6* and Christopher P. Toseland1* 1Department of Oncology and Metabolism, University of Sheffield, Sheffield, S10 2RX, UK.2University of Göttingen, 3rd Institute of Physics – Biophysics, Göttingen, 37077, Germany. 3School of Biosciences, University of Kent, Canterbury, CT2 7NJ, UK. 4Central Laser Facility, Research Complex at Harwell, Science and Technology Facilities Council, Rutherford Appleton Laboratory, Harwell, Didcot, Oxford OX11 0QX, UK. 5Advanced Imaging Center, HHMI Janelia Research Campus, Ashburn, USA. 6University of Bayreuth, Experimental Physics 1, Bayreuth, 95440, Germany. *Corresponding Authors: Florian Rehfeldt [email protected] & Christopher P. Toseland [email protected] Key words: Mechanics, DNA damage, DNA organisation, Nucleus ABSTRACT Cisplatin, specifically, creates adducts within the DNA double-strand breaks (DSBs) drive genomic double helix, which then lead to double-strand instability. For efficient and accurate repair of breaks (DSBs) in the DNA during replication, these DNA lesions, the cell activates DNA through replication-fork collapse3. damage repair pathways. However, it remains DSBs can result in large genomic aberrations and unknown how these processes may affect the are, therefore, the most deleterious to the cell. -
CRISPR Foki Dead Cas9 System: Principles and Applications in Genome Engineering
cells Review CRISPR FokI Dead Cas9 System: Principles and Applications in Genome Engineering Maryam Saifaldeen y, Dana E. Al-Ansari y , Dindial Ramotar * and Mustapha Aouida * College of Health and Life Sciences, Division of Biological and Biomedical Sciences, Hamad Bin Khalifa University, Education City, Qatar Foundation, Doha P.O.Box 34110, Qatar; [email protected] (M.S.); [email protected] (D.E.A.-A.) * Correspondence: [email protected] (D.R.); [email protected] (M.A.) These authors contributed equally to this work. y Received: 27 September 2020; Accepted: 19 November 2020; Published: 21 November 2020 Abstract: The identification of the robust clustered regularly interspersed short palindromic repeats (CRISPR) associated endonuclease (Cas9) system gene-editing tool has opened up a wide range of potential therapeutic applications that were restricted by more complex tools, including zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs). Nevertheless, the high frequency of CRISPR system off-target activity still limits its applications, and, thus, advanced strategies for highly specific CRISPR/Cas9-mediated genome editing are continuously under development including CRISPR–FokI dead Cas9 (fdCas9). fdCas9 system is derived from linking a FokI endonuclease catalytic domain to an inactive Cas9 protein and requires a pair of guide sgRNAs that bind to the sense and antisense strands of the DNA in a protospacer adjacent motif (PAM)-out orientation, with a defined spacer sequence range around the target site. The dimerization of FokI domains generates DNA double-strand breaks, which activates the DNA repair machinery and results in genomic edit. So far, all the engineered fdCas9 variants have shown promising gene-editing activities in human cells when compared to other platforms. -
Staining, and in Situ Digestion with Restriction Endonucleases
Heredity66 (1991) 403—409 Received 23 August 1990 Genetical Society of Great Britain An analysis of coho salmon chromatin by means of C-banding, AG- and fluorochrome staining, and in situ digestion with restriction endonucleases R. LOZANO, C. RUIZ REJON* & M. RUIZ REJON* Departamento de Biologia Animal, Ecologia y Genética. E. /ngenierIa T. AgrIcola, Campus Universitario de Almeria, 04120 AlmerIa and *Facu/tad de Ciencias, 18071 Granada, Universidad de Granada, Spain Thechromosome complement of the coho salmon (Oncorhynchus kisutch) has been analysed by means of C-banding, silver and fluorochrome staining, and in situ digestion with restriction endo- nucleases. C-banding shows heterochromatic regions in the centromeres of most chromosomes but not in the telomeric areas. The fifteenth metacentric chromosome pair contains a large block of constitutive heterochromatin, which occupies almost all of one chromosome arm. This region is also the site where the ribosomal cistrons are located and it reacts positively to CMA3/DA fluorochrome staining. The NORs are subject to chromosome polymorphism, which might be explicable in terms of an amplification of ribosomal cistrons. The digestion banding patterns produced by four types of restriction endonucleases on the euchromatic and heterochromatic regions are described. Two kinds of highly repetitive DNAs can be distinguished and the role of restriction endonucleases as a valuable tool in chromosome characterization studies, as well as in the analysis of the structure and organization of fish chromatin, are also discussed. Keywords:C-banding,coho salmon, fluorochrome staining, restriction endonuclease banding. (Oncorhynchus kisutch), as well as applying conven- Introduction tional banding techniques, we have analysed the Theuse of restriction endonucleases (REs) is becom- mitotic chromosomes using DNA base-pair-specific ing common not only in molecular biology but also as fluorochromes and in situ digestion with restriction an important tool in molecular cytogenetics.